Graeme Nimmo

853 total citations
17 papers, 335 citations indexed

About

Graeme Nimmo is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Graeme Nimmo has authored 17 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Physiology and 4 papers in Cell Biology. Recurrent topics in Graeme Nimmo's work include Cellular transport and secretion (4 papers), Metabolism and Genetic Disorders (3 papers) and Lysosomal Storage Disorders Research (3 papers). Graeme Nimmo is often cited by papers focused on Cellular transport and secretion (4 papers), Metabolism and Genetic Disorders (3 papers) and Lysosomal Storage Disorders Research (3 papers). Graeme Nimmo collaborates with scholars based in Canada, United States and United Kingdom. Graeme Nimmo's co-authors include Nancy Braverman, Shin‐Ichi Aizawa, Sandy Y. M. Ng, Ilana Saltzman, Bonnie Chaban, Ken F. Jarrell, Ann B. Moser, Steven J. Steinberg, Chantal Autexier and Sarn Jiralerspong and has published in prestigious journals such as Human Molecular Genetics, Molecular Microbiology and Cancer Letters.

In The Last Decade

Graeme Nimmo

16 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Graeme Nimmo Canada 9 256 77 56 46 36 17 335
R. Nair Finland 10 265 1.0× 28 0.4× 41 0.7× 84 1.8× 30 0.8× 12 380
Şükrü Anıl Doğan Germany 9 447 1.7× 79 1.0× 107 1.9× 109 2.4× 32 0.9× 14 597
Janne Purhonen Finland 10 430 1.7× 49 0.6× 41 0.7× 49 1.1× 87 2.4× 15 565
Jinping Ma China 7 341 1.3× 30 0.4× 30 0.5× 65 1.4× 25 0.7× 9 429
Marris G. Dibley Australia 4 502 2.0× 38 0.5× 52 0.9× 132 2.9× 37 1.0× 4 585
David W. Nees United States 8 260 1.0× 30 0.4× 45 0.8× 46 1.0× 50 1.4× 11 436
Lukáš Stibůrek Czechia 13 556 2.2× 35 0.5× 63 1.1× 148 3.2× 44 1.2× 15 660
Rhonda S. Lovell United States 6 340 1.3× 45 0.6× 59 1.1× 67 1.5× 38 1.1× 7 395
Iman Haddad France 13 164 0.6× 44 0.6× 27 0.5× 14 0.3× 28 0.8× 16 447
Jelmi uit de Bos Netherlands 6 270 1.1× 23 0.3× 43 0.8× 49 1.1× 51 1.4× 6 387

Countries citing papers authored by Graeme Nimmo

Since Specialization
Citations

This map shows the geographic impact of Graeme Nimmo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graeme Nimmo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graeme Nimmo more than expected).

Fields of papers citing papers by Graeme Nimmo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graeme Nimmo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graeme Nimmo. The network helps show where Graeme Nimmo may publish in the future.

Co-authorship network of co-authors of Graeme Nimmo

This figure shows the co-authorship network connecting the top 25 collaborators of Graeme Nimmo. A scholar is included among the top collaborators of Graeme Nimmo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graeme Nimmo. Graeme Nimmo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Miron, Marie‐Claude, et al.. (2025). An analysis of bone marrow burden scores in a retrospective analysis of adult patients with type 1 Gaucher disease. Blood Cells Molecules and Diseases. 113-114. 102933–102933.
2.
Piran, Siavash, et al.. (2024). The natural history of Gaucher disease type 1 in 31 patients over a median of 15 years: a retrospective study. Internal Medicine Journal. 54(10). 1661–1668. 2 indexed citations
3.
Kalia, Lorraine V., Graeme Nimmo, & Tiago Mestre. (2023). Genetic Testing in Clinical Movement Disorders: A Case-Based Review. Seminars in Neurology. 43(1). 147–155. 1 indexed citations
4.
Tavares, Erika, Graeme Nimmo, Tara Paton, et al.. (2022). Deep intronic variant in MVK as a cause for mevalonic aciduria initially presenting as non‐syndromic retinitis pigmentosa. Clinical Genetics. 102(6). 524–529. 4 indexed citations
5.
Bourque, Danielle K., Dawn Cordeiro, Graeme Nimmo, Jeff Kobayashi, & Saadet Mercimek‐Andrews. (2021). Phenotypic and Genotypic Spectrum of Glucose Transporter-1 Deficiency Syndrome. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48(6). 1–5. 8 indexed citations
6.
Oliveira, L.M. de, Graeme Nimmo, Jay P. Ross, et al.. (2021). Occurrence of Amyotrophic Lateral Sclerosis in Type 1 Gaucher Disease. Neurology Genetics. 7(4). e600–e600. 4 indexed citations
7.
Yoon, Grace, Graeme Nimmo, Christopher M. Gómez, et al.. (2020). De Novo variants in EEF2 cause a neurodevelopmental disorder with benign external hydrocephalus. Human Molecular Genetics. 29(24). 3892–3899. 10 indexed citations
8.
Nimmo, Graeme, Sundararajan Venkatesh, Ashutosh Pandey, et al.. (2018). Bi-allelic mutations ofLONP1encoding the mitochondrial LonP1 protease cause pyruvate dehydrogenase deficiency and profound neurodegeneration with progressive cerebellar atrophy. Human Molecular Genetics. 28(2). 290–306. 30 indexed citations
9.
Nimmo, Graeme, Resham Ejaz, Dawn Cordeiro, Pekka Kannus, & Saadet Mercimek‐Andrews. (2017). Riboflavin transporter deficiency mimicking mitochondrial myopathy caused by complex II deficiency. American Journal of Medical Genetics Part A. 176(2). 399–403. 21 indexed citations
10.
Nimmo, Graeme, et al.. (2015). Triplication of 16p12.1p12.3 associated with developmental and growth delay and distinctive facial features. American Journal of Medical Genetics Part A. 170(3). 712–716. 2 indexed citations
12.
Jiralerspong, Sarn, Graeme Nimmo, Melissa L. Loscalzo, et al.. (2011). Functional characterization of novel mutations in GNPAT and AGPS, causing rhizomelic chondrodysplasia punctata (RCDP) types 2 and 3. Human Mutation. 33(1). 189–197. 54 indexed citations
13.
Nimmo, Graeme, et al.. (2010). Rhizomelic chrondrodysplasia punctata type 2 resulting from paternal isodisomy of chromosome 1. American Journal of Medical Genetics Part A. 152A(7). 1812–1817. 22 indexed citations
14.
Braverman, Nancy, Rui Zhang, Li Chen, et al.. (2009). A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton. Molecular Genetics and Metabolism. 99(4). 408–416. 51 indexed citations
15.
Marie‐Egyptienne, Delphine T., et al.. (2008). Growth defects in mouse telomerase RNA-deficient cells expressing a template-mutated mouse telomerase RNA. Cancer Letters. 275(2). 266–276. 7 indexed citations
16.
Fakhoury, Johans, Graeme Nimmo, & Chantal Autexier. (2007). Harnessing Telomerase in Cancer Therapeutics. Anti-Cancer Agents in Medicinal Chemistry. 7(4). 475–483. 17 indexed citations
17.
Chaban, Bonnie, Sandy Y. M. Ng, Ilana Saltzman, et al.. (2007). Systematic deletion analyses of the fla genes in the flagella operon identify several genes essential for proper assembly and function of flagella in the archaeon, Methanococcus maripaludis. Molecular Microbiology. 66(3). 596–609. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026